Liaoning Cheng Da Co., Ltd. (SHA:600739)
China · Delayed Price · Currency is CNY 12.03
-0.02 (-0.17%)
At close: Feb 6, 2026
Liaoning Cheng Da Revenue
Liaoning Cheng Da had revenue of 2.77B CNY in the quarter ending September 30, 2025, a decrease of -4.27%. This brings the company's revenue in the last twelve months to 11.12B, down -1.53% year-over-year. In the year 2024, Liaoning Cheng Da had annual revenue of 11.29B with 4.70% growth.
Revenue (ttm)
11.12B
Revenue Growth
-1.53%
P/S Ratio
1.65
Revenue / Employee
3.35M
Employees
3,317
Market Cap
18.31B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 11.29B | 506.45M | 4.70% |
| Dec 31, 2023 | 10.78B | -3.78B | -25.97% |
| Dec 31, 2022 | 14.56B | -3.81B | -20.73% |
| Dec 31, 2021 | 18.37B | 1.43B | 8.43% |
| Dec 31, 2020 | 16.94B | -800.78M | -4.51% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Pharmaceuticals Holding | 280.69B |
| Jointown Pharmaceutical Group | 157.71B |
| C.Q. Pharmaceutical Holding | 83.08B |
| Guangzhou Baiyunshan Pharmaceutical Holdings Company | 77.54B |
| China National Accord Medicines Corporation | 73.04B |
| China National Medicines Corporation | 51.95B |
| China Meheco Group | 33.23B |
| Guangxi LiuYao Group | 20.95B |